AHEAD Program for Type 1 Diabetes
(AHEAD Program Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if the AHEAD Program, a specialized support program, helps young adults with type 1 diabetes better manage their blood sugar levels during the transition from pediatric to adult healthcare. Participants will either continue with their usual diabetes care or receive additional support from a specialized team to enhance their independence in managing diabetes. The study will compare blood sugar changes and participants' experiences between the two groups. This trial suits individuals aged 16-19 who have had type 1 diabetes for at least a year and are currently receiving care at a specific diabetes clinic in Washington State. As an unphased trial, it offers participants the opportunity to contribute to valuable research that could improve diabetes care for young adults.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your usual diabetes care, but it's best to confirm with the trial organizers.
What prior data suggests that the AHEAD Program is safe for emerging adults with type 1 diabetes?
Research shows that the AHEAD Program could be a safe choice for young adults with type 1 diabetes. Previous studies found that this program helps reduce the emotional stress of daily diabetes management. No reports of serious safety issues or negative effects related to the program suggest that participants handle it well.
The AHEAD Program offers personalized support to help young adults manage their diabetes more independently, which is crucial when transitioning from child to adult care. Although specific safety details aren't provided, the absence of negative reports indicates its safety.12345Why are researchers excited about this trial?
The AHEAD Program is unique because it focuses on providing comprehensive support from a specialized team of diabetes experts who help older adolescents and young adults gain the skills and confidence to manage their Type 1 diabetes independently. Unlike standard treatments that primarily involve insulin management and regular health check-ups, the AHEAD Program emphasizes building autonomy and competence in managing diabetes, which can be particularly empowering for young individuals transitioning to self-care. Researchers are excited about this approach because it could lead to better long-term health outcomes and improved quality of life for young people with Type 1 diabetes.
What evidence suggests that the AHEAD Program is effective for improving blood glucose management in emerging adults with type 1 diabetes?
Research shows that the AHEAD Program, which participants in this trial may receive, can help young adults with type 1 diabetes manage their blood sugar more effectively. Studies have found that the program reduces the stress of managing diabetes, and less stress can lead to better blood sugar control. The program teaches skills for managing diabetes more independently, potentially easing the transition from child to adult healthcare.16789
Who Is on the Research Team?
Faisal S Malik, MD, MSc
Principal Investigator
University of British Columbia
Are You a Good Fit for This Trial?
This trial is for emerging adults with Type 1 Diabetes transitioning from pediatric to adult care. Participants should be interested in a program designed to support their independence in managing diabetes.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the AHEAD Program or Usual Care, with clinic visits every three months
Follow-up
Participants are monitored for changes in glycemia and participant-reported outcomes after the intervention period
What Are the Treatments Tested in This Trial?
Interventions
- AHEAD Program
Trial Overview
The study tests the AHEAD Program, which offers tailored support for young adults with Type 1 Diabetes, against usual care. It aims to see if this program leads to better blood glucose control and self-reported outcomes.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
AHEAD participants will receive support from a team of diabetes providers with expertise in supporting older adolescents and young adults who will work to build autonomy and competence needed to manage diabetes independently.
Usual Care participants will receive diabetes care as currently being provided by their primary medical team.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of British Columbia
Lead Sponsor
Seattle Children's Hospital
Collaborator
Kaiser Permanente
Collaborator
University of Washington
Collaborator
Breakthrough T1D
Collaborator
Citations
NCT07292558 | Achieving Health in Emerging Adults With ...
Type 1 Diabetes Leads to Improved Diabetes Outcomes. outcomes between groups. Higher scores indicate higher diabetes distress (score: 14-84).
AHEAD Program May Improve Diabetes Distress Among ...
The AHEAD program was associated with promising reductions in mean diabetes distress scores among emerging adults with type 1 diabetes.
Design of the Advancing Care for Type 1 Diabetes and ...
Phase 1 calorimetry data informed calorie prescriptions for the hypocaloric Look AHEAD (i.e., low fat) and Low Carbohydrate diets.
Multi-step ahead predictive model for blood glucose ...
The illustrated experimental results derived from clinical data for 97 T1D patients show the effectiveness of our proposed model in forecasting ...
We Are on the Verge of Breakthrough Cures for Type 1 ...
We estimated 2.07 million T1DM patients nationally across all insurance coverages in our 2024 baseline model year: 1.79 million adults (≥20 years) and 0.28 ...
Hospitals Advance AI-Enabled Prevention at Scale | AHA
After 12 months, about one-third of participants in each group met Centers for Disease Control and Prevention benchmarks for lowering diabetes ...
AHEAD Program May Improve Diabetes Distress Among ...
The AHEAD program was associated with promising reductions in mean diabetes distress scores among emerging adults with type 1 diabetes.
Action for Health in Diabetes (Look AHEAD)
The Look AHEAD study was designed to test whether weight loss similarly improved cardiovascular morbidity and mortality in patients with type 2 diabetes.
Safety and Glycemic Outcomes of the MiniMed 780G ...
Conclusions: MM780G use with the Simplera Sync sensor is safe and demonstrated improved glycemic outcomes in both pediatric and adult ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.